Scientists have identified a new drug that is effective at inhibiting the development of plaques

Alzheimer’s is a developmental neurodegenerative disease affecting 6 million Americans with a projected increase to 13 million by 2050. Currently, there is no cure; however, in recent series of studies in animals, scientists have shown that a drug that modulates the behavior of one enzyme reduces the formation of plaques, which is a hallmark of Alzheimer’s disease. If these findings can be corroborated, this could pave the way for clinical trials in humans. Read the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org